These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8416325)

  • 1. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.
    Viscoli CM; Horwitz RI; Singer BH
    Ann Intern Med; 1993 Jan; 118(2):99-105. PubMed ID: 8416325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propranolol in postinfarction patients with mechanical or electrical complications.
    Furberg CD; Hawkins CM; Lichstein E
    Circulation; 1984 Apr; 69(4):761-5. PubMed ID: 6365352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.
    Byington RP; Worthy J; Craven T; Furberg CD
    Am J Cardiol; 1990 Jun; 65(20):1287-91. PubMed ID: 2188492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of treatment adherence to the risk of death after myocardial infarction in women.
    Gallagher EJ; Viscoli CM; Horwitz RI
    JAMA; 1993 Aug; 270(6):742-4. PubMed ID: 8336377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction.
    Rochon PA; Tu JV; Anderson GM; Gurwitz JH; Clark JP; Lau P; Szalai JP; Sykora K; Naylor CD
    Lancet; 2000 Aug; 356(9230):639-44. PubMed ID: 10968437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.
    Friedman LM; Byington RP; Capone RJ; Furberg CD; Goldstein S; Lichstein E
    J Am Coll Cardiol; 1986 Jan; 7(1):1-8. PubMed ID: 3510232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.